2841. A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate (TZD) and Linezolid (LZD) for Treatment of Ventilated Gram-Positive (G+) Nosocomial Pneumonia

BACKGROUND: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are frequently caused by G+ cocci; TZD has potent in vitro activity against these pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The VITAL study compared the efficacy and safety of TZD v...

Descripción completa

Detalles Bibliográficos
Autores principales: Wunderink, Richard G, Roquilly, Antoine, Croce, Martin, Rodriguez Gonzalez, Daniel, Fujimi, Satoshi, Butterton, Joan R, Broyde, Natasha, Popejoy, Myra W, Kim, Jason Y, De Anda, Carisa S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808920/
http://dx.doi.org/10.1093/ofid/ofz359.146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808920/
http://dx.doi.org/10.1093/ofid/ofz359.146

Ejemplares similares